{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:28:35Z","timestamp":1785817715550,"version":"3.56.0"},"reference-count":24,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2018,3,17]],"date-time":"2018-03-17T00:00:00Z","timestamp":1521244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2018,3,17]],"date-time":"2018-03-17T00:00:00Z","timestamp":1521244800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"GeneDx","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Journal of Genetic Counseling"],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Genetic testing for inherited cancer risk has recently improved through the advent of multi\u2010gene panels and the addition of deletion and duplication analysis of the <jats:italic>BRCA<\/jats:italic> genes. The primary aim of this study was to determine which factors influence the intent of individuals with a personal history of breast and\/or ovarian cancer and negative or uncertain <jats:italic>BRCA1<\/jats:italic> and <jats:italic>BRCA2<\/jats:italic> testing to return to a hereditary cancer program for additional genetic risk assessment, counseling, and testing. Surveys were sent to 1197 individuals and 257 were returned. Of those participants who were planning to return to clinic, most cited having family members who could benefit from the test result as the primary motivation to return. Many participants who were not planning to return to clinic cited the cost of testing as a barrier to return. Cost of testing and concerns about insurance coverage were the most commonly cited barriers for the group of participants who were undecided about returning to clinic. Results from this study may be used to guide re\u2010contact efforts by clinicians to increase patient uptake to return to clinic for up\u2010to\u2010date genetic risk assessment, counseling, and testing.<\/jats:p>","DOI":"10.1007\/s10897-018-0241-9","type":"journal-article","created":{"date-parts":[[2018,3,17]],"date-time":"2018-03-17T09:05:40Z","timestamp":1521277540000},"page":"1210-1219","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Factors Influencing Clinical Follow\u2010Up for Individuals with a Personal History of Breast and\/or Ovarian Cancer and Previous Uninformative <i>BRCA1<\/i> and <i>BRCA2<\/i> Testing"],"prefix":"10.1002","volume":"27","author":[{"given":"Sarah E.","family":"Chadwell","sequence":"first","affiliation":[{"name":"Genetic Counseling Program, College of Medicine University of Cincinnati and Division of Human Genetics, Cincinnati Children's Hospital Medical Center 3333 Burnet Avenue ML 4006 Cincinnati OH 45229 USA"},{"name":"Division of Human Genetics Cincinnati Children's Hospital Cincinnati OH USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"He","sequence":"additional","affiliation":[{"name":"Division of Human Genetics Cincinnati Children's Hospital Cincinnati OH USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Knapke","sequence":"additional","affiliation":[{"name":"Inherited Cancer, GeneDx Gaithersburg MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Lewis","sequence":"additional","affiliation":[{"name":"Department of Surgery University of Cincinnati College of Medicine Cincinnati OH USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Sisson","sequence":"additional","affiliation":[{"name":"Division of Human Genetics Cincinnati Children's Hospital Cincinnati OH USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hopper","sequence":"additional","affiliation":[{"name":"Division of Human Genetics Cincinnati Children's Hospital Cincinnati OH USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,3,17]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-012-2511-3"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/1049732303013006008"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2014.16"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-7625.2008.00494.x"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2014.0227"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10897-014-9714-7"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10897-016-0001-7"},{"issue":"82","key":"e_1_2_12_9_1","article-title":"Evaluation of the need for routine clinical testing of PALB2 c.1592delT mutation in BRCA negative Northern Finnish breast cancer families","volume":"14","author":"Haanpaa M.","year":"2013","journal-title":"BMC Medical Genetics"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10897-009-9254-8"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10897-014-9695-6"},{"key":"e_1_2_12_12_1","unstructured":"Howlader N. Noone A.M. Krapcho M. Miller D. Bishop K. Altekruse S.F. et al. (2016)SEER cancer statistics review 1975\u20102013 National Cancer Institute.Bethesda MD http:\/\/seer.cancer.gov\/csr\/1975_2013\/ based on November 2015 SEER data submission posted to the SEER web site April 2016."},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27556"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199705153362003"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.6607"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.2307\/2529310"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2013.160"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2014.07.012"},{"key":"e_1_2_12_19_1","doi-asserted-by":"crossref","unstructured":"Moran O. Nikitina D. Royer R. Poll A. Metcalfe K. Narod S. A et al. (2016).Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12\u2010gene panel.Breast Cancer Research and Treatment 1\u20138. doi: 10.1007\/s10549\u2010016\u20104038\u2010y.","DOI":"10.1007\/s10549-016-4038-y"},{"key":"e_1_2_12_20_1","volume-title":"GeneReviews\u00ae [Internet]","author":"Petrucelli N.","year":"2016"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1037\/fsh0000103"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.166"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29010"},{"key":"e_1_2_12_24_1","unstructured":"Vaccari E. Yackowski L. Hussong M. Murphy P. Cremona M. Booker J.et al. (2015).Characterizing the clinical presentation of individuals with pathogrnic variants in a breast\/ovarian cancer gene panel: GeneDx."},{"issue":"1","key":"e_1_2_12_25_1","first-page":"s37","article-title":"Characteristics of donors who do or do not return to give blood and barriers to their return","volume":"12","author":"Wevers A.","year":"2014","journal-title":"Blood Transfusion"}],"container-title":["Journal of Genetic Counseling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10897-018-0241-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10897-018-0241-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10897-018-0241-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s10897-018-0241-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T12:38:23Z","timestamp":1694781503000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1007\/s10897-018-0241-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,17]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1007\/s10897-018-0241-9"],"URL":"https:\/\/doi.org\/10.1007\/s10897-018-0241-9","archive":["Portico"],"relation":{},"ISSN":["1059-7700","1573-3599"],"issn-type":[{"value":"1059-7700","type":"print"},{"value":"1573-3599","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,17]]}}}